← Back to Search

Exercise + Calcium Supplementation for Osteoporosis (ESkAPE Trial)

N/A
Waitlist Available
Led By Wendy M Kohrt, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women will be premenopausal with regular menstrual cycles or postmenopausal, defined as absence of menses for at least 12 mo or, in those who underwent a hysterectomy, a serum follicle stimulating hormone (FSH) >30 mIU/mL
Female and male Veterans aged 25 to 45 y and 55 to 75 y
Must not have
Impaired renal function, defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2
Fracture in the past 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up bmd of the lumbar spine and proximal femur is measured at baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether pre-exercise supplemental calcium can help improve bone health for veterans by looking at the effects of exercise on blood calcium levels.

Who is the study for?
This trial is for male and female Veterans aged 25-45 and 55-75 who are normally active but not in regular intense exercise. Women must be pre or postmenopausal with specific hormonal levels. Exclusions include severe bone density loss, kidney issues, uncontrolled thyroid/blood calcium levels, high blood pressure, type 1 diabetes, recent fractures, obesity, certain heart conditions or anemia.
What is being tested?
The study tests if taking supplemental calcium before endurance exercises can help maintain blood calcium levels during workouts to improve bone health. It aims to provide better exercise and nutrition guidelines to reduce fracture risk in Veterans.
What are the potential side effects?
While the trial does not mention specific side effects of the interventions (exercise and potential calcium supplements), common concerns may include muscle soreness from exercise or gastrointestinal discomfort from supplements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman who is either premenopausal with regular periods or postmenopausal.
Select...
I am a veteran aged between 25-45 or 55-75.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My kidney function is reduced, with an eGFR below 60.
Select...
I have had a bone fracture in the last 6 months.
Select...
I have type 2 diabetes and am on insulin or sulfonylurea therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~serum po4 is measured before (-15, 0 minutes), during (15, 30, 45, 60 minutes), and after (15, 30, 60, 120, 180, 240 minutes, 24 hours) the 1st, 8th, and 16th exercise sessions
This trial's timeline: 3 weeks for screening, Varies for treatment, and serum po4 is measured before (-15, 0 minutes), during (15, 30, 45, 60 minutes), and after (15, 30, 60, 120, 180, 240 minutes, 24 hours) the 1st, 8th, and 16th exercise sessions for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
C-terminal peptide of type 1 collagen (CTX)
Procollagen 1 intact N-terminal propeptide (P1NP)
Secondary study objectives
Hematocrit (Hct)
Hemoglobin (Hgb)
P1NP
+5 more
Other study objectives
Bone mineral density (BMD)
Fat mass (FM)
Fat-free mass (FFM)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExerciseExperimental Treatment1 Intervention
All participants engage in exercise training

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,660 Previous Clinical Trials
3,361,585 Total Patients Enrolled
3 Trials studying Exercise
598 Patients Enrolled for Exercise
Wendy M Kohrt, PhDPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
2 Previous Clinical Trials
136 Total Patients Enrolled

Media Library

Endurance exercise intervention Clinical Trial Eligibility Overview. Trial Name: NCT05029128 — N/A
Exercise Research Study Groups: Exercise
Exercise Clinical Trial 2023: Endurance exercise intervention Highlights & Side Effects. Trial Name: NCT05029128 — N/A
Endurance exercise intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05029128 — N/A
~6 spots leftby Nov 2025